Actinium Pharmaceuticals, Inc. Business Finance Contracts & Agreements
53 Contracts & Agreements
- Assignment Agreements (4 contracts)
- Exchange Agreements (2)
- Investment Agreements (1)
- Investor Rights Agreements (3)
- Purchase Agreements (4)
- Registration Rights Agreements (3)
- Stock Agreements (16)
- Subscription Agreements (2)
- Underwriting Agreements (4)
- Warrant Agreements (14)
- Amendment to Warrant to Purchase Common Stock of Actinium Pharmaceuticals, Inc., dated March 14, 2017, issued to Sandesh Seth (Filed With SEC on August 14, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on June 18, 2020)
- Form of Pre-funded Warrant (Filed With SEC on June 18, 2020)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on April 24, 2020)
- Underwriting Agreement, dated as of April 21, 2020, by and between Actinium Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on April 24, 2020)
- Form of Warrant (Filed With SEC on April 18, 2019)
- Underwriting Agreement, dated as of April 18, 2019, by and between Actinium Pharmaceuticals, Inc. and William Blair & Company, L.L.C (Filed With SEC on April 18, 2019)
- Seventh Amendment to the 2013 Amended and Restated Stock Plan, as amended (Filed With SEC on March 15, 2019)
- Amendment to Actinium Pharmaceuticals, Inc. Warrant to Purchase Common Stock, dated November 8, 2018 issued to Bioche Asset Management, LLC (Filed With SEC on November 9, 2018)
- Amendment to Actinium Pharmaceuticals, Inc. Warrant to Purchase Common Stock, dated November 8, 2018 issued to Carnegie Hill Partners (Filed With SEC on November 9, 2018)
- Amendment to Actinium Pharmaceuticals, Inc. Warrant to Purchase Common Stock, dated November 8, 2018 issued to Amosan LLC (Filed With SEC on November 9, 2018)
- Registration Rights Agreement, dated as of October 18, 2018, by and between Actinium Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on October 18, 2018)
- Purchase Agreement, dated as of October 18, 2018, by and between Actinium Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on October 18, 2018)
- Confidential Information and Invention Assignment Agreement, dated April 27, 2018, by and between Jeffrey W. Chell and Actinium Pharmaceuticals, Inc (Filed With SEC on May 1, 2018)
- Sixth Amendment to the 2013 Amended and Restated Stock Plan, as amended (Filed With SEC on March 16, 2018)
- Revised Form of Non-Transferable Subscription Rights Certificate (Filed With SEC on February 26, 2018)
- Form of Non-Transferable Subscription Rights Certificate (Filed With SEC on February 15, 2018)
- Form of Series B Warrant (Filed With SEC on February 15, 2018)
- Form of Series A Warrant (Filed With SEC on February 15, 2018)
- Form of Warrant Agency Agreement between Action Stock Transfer Corporation and Actinium Pharmaceuticals, Inc (Filed With SEC on February 15, 2018)
- Assignment and Consent Agreement, dated June 6, 2017, among 275 Madison Avenue RPW 1 LLC, 275 Madison Avenue RPW 2, LLC, Actinium Pharmaceuticals, Inc. and Relmada Therapeutics,... (Filed With SEC on August 4, 2017)
- Form of Warrant (Filed With SEC on July 28, 2017)
- Underwriting Agreement, dated as of July 28, 2017, by and between Actinium Pharmaceuticals, Inc. and Oppenheimer & Co. Inc.. as representative of the several underwriters party... (Filed With SEC on July 28, 2017)
- ActiniumPharmaceuticals, Inc. CONFIDENTIALINFORMATION AND INVENTION ASSIGNMENT AGREEMENT (Filed With SEC on March 28, 2017)
- ActiniumPharmaceuticals, Inc. CONFIDENTIALINFORMATION AND INVENTION ASSIGNMENT AGREEMENT (Filed With SEC on March 16, 2017)
- WARRANTTO PURCHASE COMMON STOCK of ACTINIUMPHARMACEUTICALS, INC. Voidafter February 11, 2022 (Filed With SEC on March 16, 2017)
- AMENDMENT TO ACTINIUM PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on March 16, 2017)
- AMENDMENT TO ACTINIUM PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on March 16, 2017)
- AMENDMENTNO. 5 TO ACTINIUM PHARMACEUTICALS, INC. 2013 AMENDED AND RESTATED STOCK PLAN (Filed With SEC on March 16, 2017)
- ACTINIUM PHARMACEUTICALS, INC. FOURTH AMENDMENT TO THE AMENDED AND RESTATED 2013 STOCK PLAN (Filed With SEC on December 14, 2016)
- THIRD AMENDMENT TO ACTINIUM PHARMACEUTICALS, INC. 2013 AMENDED AND RESTATED STOCK PLAN (Filed With SEC on March 11, 2016)
- INVESTORS’RIGHTS AGREEMENT BY AND BETWEEN ACTINIUM PHARMACEUTICALS, INC. AND MEMORIAL SLOAN KETTERING CANCER CENTER (Filed With SEC on December 24, 2015)
- ACTINIUM PHARMACEUTICALS, INC. SECOND AMENDMENT TO THE AMENDED AND RESTATED 2013 STOCK PLAN (Filed With SEC on December 16, 2015)
- ACTINIUM PHARMACEUTICALS, INC. FIRST AMENDMENT TO THE AMENDED AND RESTATED 2013 STOCK PLAN (Filed With SEC on August 7, 2015)
- ACTINIUM PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share Placement Agent Agreement (Filed With SEC on June 5, 2015)
- ACTINIUMPHARMACEUTICALS, INC. Amendedand Restated Stock Plan (Filed With SEC on March 16, 2015)
- ACTINIUM PHARMACEUTICALS, INC. Warrantto Purchase Common Stock (Filed With SEC on February 6, 2015)
- ACTINIUMPHARMACEUTICALS, INC. CommonStock, par value $0.001 per share Warrantsto Purchase Shares of Common Stock UnderwritingAgreement (Filed With SEC on February 6, 2015)
- ACTINIUM PHARMACEUTICALS, INC. 1,670,000 Shares Common Stock ($0.001 par value) Underwriting Agreement Underwriting Agreement (Filed With SEC on June 25, 2014)
- ACTINIUM PHARMACEUTICALS, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 31, 2014)
